MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 53 filers reported holding MEI PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $109,000 | -92.2% | 25,582 | -87.3% | 0.01% | -93.8% |
| Q3 2014 | $1,391,000 | +8.8% | 201,600 | 0.0% | 0.19% | +11.5% |
| Q2 2014 | $1,278,000 | -15.6% | 201,600 | +48.1% | 0.17% | -26.0% |
| Q1 2014 | $1,515,000 | +204.8% | 136,100 | +119.2% | 0.24% | +53.6% |
| Q4 2013 | $497,000 | – | 62,100 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |